We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Dec 20
Forxiga is claimed to be the first approved SGLT2 inhibitor for chronic heart failure with reduced ejection fraction…
01 Dec 20
Dupixent is a fully-human monoclonal antibody discovered using Regeneron's original VelocImmune technology
The Japanese regulatory approval of cabometyx is based on results from two clinical trials: Phase 3 CELESTIAL and…
The select anti-allergy brands are being acquired in Russia, Ukraine, Kazakhstan and Uzbekistan
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
27 Nov 20
BioInvent will receive up to 3.52m for the development, scale-up, supply of material for toxicological studies and clinical…
27 Nov 20
CX-5461 works to stabilise DNA G-quadruplexes of cancer cells and facilitates disruption of the replication fork in cancer…
26 Nov 20
Janssen claimed that its Tremfya is the first selective IL-23 p19 subunit inhibitor licensed for both the treatment…
26 Nov 20
FDA indicated danyelza in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of neuroblastoma
25 Nov 20
The EC approval is based on Phase 3 ATTRACTION-3 trial, which showed positive results for Opdivo in improving…
25 Nov 20
Roche claims that Xofluza is the first single-dose influenza medicine approved to prevent influenza for post-exposure prophylaxis
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates